Expert Opinion on Pharmacotherapy

Papers
(The H4-Index of Expert Opinion on Pharmacotherapy is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Perspectives on the pharmacological management of dystonia52
Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancer31
Intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis31
An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer28
Fixed-dose combination amlodipine–celecoxib for treatment of hypertension and osteoarthritis pain: an up-to-date evaluation28
The pharmacotherapeutic management of pulmonary tuberculosis: an update of the state-of-the-art24
Sodium–glucose cotransporter 2 inhibitors for the management of type 2 diabetes24
Letter to editor – a response to: ‘efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review’24
The pharmacotherapeutic management of hyperkalemia in patients with cardiovascular disease23
Pharmacotherapy developments in autophagy inhibitors for bladder cancer23
An overview of cilastatin + imipenem + relebactam as a therapeutic option for hospital-acquired and ventilator-associated bacterial pneumonia: evidence to date23
An update on the efficacy of Venetoclax for chronic lymphocytic leukemia22
What must be considered when prescribing hormonal pharmacotherapy for male infertility?22
Moving beyond ruxolitinib failure in myelofibrosis: evolving strategies for second line therapy22
Efficacy and safety of Isavuconazole for the treatment of invasive Aspergillus infection - an update of the literature21
The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration21
Can we rely on synthetic pharmacotherapy for the treatment of glioblastoma?21
Pharmacotherapy for post-stroke aphasia: what are the options?20
GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives20
0.10412311553955